title: Nicotine dependence and psychiatric disorders.
abstract: Nicotine addiction is the single largest preventable cause of morbidity and mortality in the Western World. Smoking is not any more just a bad habit, but a substance addiction problem. The pharmacological aspects of nicotine show that this substance has a broad distribution in the different body compartnents, due mainly to its lipophilic characteristic. There are nicotinic receptors as members of cholinergic receptors' family. They are located in neuromuscular junction and in the central nervous system (CNS). Although they are similar, pentameric structure with an ionic channel to sodium, there are some differences in the protein chains characteristics. Repeated administration of nicotine in rats, results in the sensitization phenomenon, which produces increase in the behavioral locomotor activity response. It has been found that most psychostimulants-induced behavioral sensitization through a nicotine receptor activation. Nicotine receptors in CNS are located mainly in presynaptic membrane and in that way they regulated the release of several neurotransmitters, among them acetylcholine, dopamine, serotonin, and norepinephrine. In some activities like sleep-wake cycle, nicotine receptors have a functional significance. Nicotine receptor stimulation promotes wake time, reduces both, total sleep time and rapid eye movement sleep (REMS). About nicotine dependence, this substance full fills all the criteria for dependence and withdrawal syndrome. There are some people that have more vulnerability for to become nicotine dependent, those are psychiatric patients. Among them schizophrenia, major depression, anxiety disorders and attention deficit disorder, represent the best example in this area. Nicotine may have some beneficial effects, among them are some neuroprotective effects in disorders like Parkinson's disease, and Gilles de la Tourette' syndrome. Also there are several evidences that support the role of nicotine in cognitive improvement functions like attention, concentration, and memory. Finally there are several strategies to deal with nicotine dependence, Nicotine Replacement Therapy (NRT), which are nicotine chewing-gum, transdermal nicotine patches, and nicotine inhalators device. Also some antidepressants like bupropion has shown to be effective in smoking cessation treatment. To know more about nicotine phenomenon would be important, because that will allow a more mature perspective about the damage and beneficial effects of that substance.
authors.affiliation: Servicio de Neurología y Psiquiatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF. salin@servidor.unam.mx
authors.forename: Rafael J
authors.initials: RJ
authors.lastname: Salín-Pascual
authors.forename: Natasha V
authors.initials: NV
authors.lastname: Alcocer-Castillejos
authors.forename: Gabriel
authors.initials: G
authors.lastname: Alejo-Galarza
mesh_terms: D000375:Aging; D016642:Bupropion / Q000627:therapeutic use; D003072:Cognition Disorders / Q000150:complications / Q000453:epidemiology; D003704:Dementia / Q000150:complications / Q000453:epidemiology; D003866:Depressive Disorder / Q000150:complications / Q000453:epidemiology; D006801:Humans; D001523:Mental Disorders / Q000150:complications*; D009069:Movement Disorders / Q000150:complications / Q000453:epidemiology; D009538:Nicotine / Q000494:pharmacology; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000453:epidemiology; D012307:Risk Factors; D012559:Schizophrenia / Q000150:complications / Q000453:epidemiology; D012890:Sleep / Q000187:drug effects; D014029:Tobacco Use Disorder / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D016642:Bupropion; D009538:Nicotine